Live Breaking News & Updates on Anant Waibase

Stay updated with breaking news from Anant waibase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Behind the antibody cocktail rush in India's Covid-19 wave, profits for hospitals and pharma firms

On December 16, Regeneron said its cocktail drug had diminished potency against Omicron. But 13 days later, Cipla held a webinar to promote its use in India. ....

United States , United Kingdom , Anant Waibase , Sanjay Nagral , Eli Lilly , Jaideep Gogtay , Mahadev Waibase , Sudhakar Shinde , Regeneron Regen , Altaf Khan , India Central Drugs Standards Control Organisation , National Institute Of Health , Indian Council Of Medical Research , National Health Service , World Health Organisation On , Navi Mumbai , Kopar Khairane , Central Drugs Standards Control Organisation , World Health Organisation , National Institute , Indian Council , Medical Research , Umbai Third Wave Omicron Antibody Therapy Treatment , Micron Regen Cov Effective , Onoclonal Antibody Treatment Omicron Effectiveness , Onoclonal Antibody Drug Cocktail Cost ,